Article Information
History
- May 1, 2021.
Article Versions
- Version 1 (April 23, 2021 - 06:24).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Hannah Wang, MD1,*,‡,
- Jacob A. Miller, MD2,*,
- Michelle Verghese, BA1,
- Mamdouh Sibai, BS3,
- Daniel Solis, BS1,
- Kenji O. Mfuh, PhD3,
- Becky Jiang, CLS3,
- Naomi Iwai, CLS3,
- Marilyn Mar, CLS3,
- ChunHong Huang, MD1,
- Fumiko Yamamoto, MS1,
- Malaya K. Sahoo, PhD1,
- James Zehnder, MD1 and
- Benjamin A. Pinsky, MD, PhD1,3,4,†
- 1Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA
- 2Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA
- 3Clinical Virology Laboratory, Stanford Health Care, Stanford, CA, USA
- 4Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA
- ↵†Corresponding Author
: Benjamin A. Pinsky, MD, PhD, 3375 Hillview, Room 2913, Palo Alto, CA 94304, Phone (650) 498-5575, Fax (650) 736-1964, bpinsky{at}stanford.edu - ↵‡Alternate Corresponding Author
:, Hannah Wang, MD, 3375 Hillview, Room 2913, Palo Alto, CA 94304, Phone (650) 498-5575, Fax (650) 736-1964, wangh1{at}stanford.edu
↵* Authors HW and JAM contributed equally to this manuscript.
Posted May 01, 2021.
Multiplex SARS-CoV-2 Genotyping PCR for Population-Level Variant Screening and Epidemiologic Surveillance
